A randomized, placebo controlled pilot trial of botulinum toxin for paratonic rigidity in people with advanced cognitive impairment.

Objective: Evaluate safety and efficacy of Incobotulinumtoxin A in elderly patients with dementia and paratonia.

Setting: University-affiliated hospital, spasticity management Clinic.

Participants: Ten subjects were enrolled.